Author:
Firouzi Fareheh,Sussman Mark A
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference10 articles.
1. Hematopoietic stem-cell senescence and myocardial repair - Coronary artery disease genotype / phenotype analysis of post-MI myocardial regeneration response induced by CABG / CD133 + bone marrow hematopoietic stem cell treatment in RCT PERFEC;Wolfien;EBioMedicine,2020
2. The IMPACT-CABG trial: a multicenter, randomized clinical trial of CD133+ stem cell therapy during coronary artery bypass grafting for ischemic cardiomyopathy;Noiseux;J Thorac Cardiovasc Surg,2016
3. Cardiac function improvement and bone marrow response-outcome analysis of the randomized PERFECT phase III clinical trial of intramyocardial CD133 + application after myocardial infarction the PERFECT trial investigators group;Steinhoff;EBioMedicine,2017
4. Hassan Naseri M., Madani H., Hossein Ahmadi Tafti S., et al. COMPARE CPM-RMI Trial: intramyocardial transplantation of autologous bone marrow-derived CD133 + Cells and MNCs during CABG in patients with recent MI: a phase II/III, multicenter, placebo-controlled, randomized, double-blind clinical trial. Cell Jn.d. 2018;20:267–77.
5. Combined coronary artery bypass surgery with bone marrow stem cell transplantation: are we there yet?;Ayyat;Ann Thorac Surg,2019
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献